Induction of Rat Intestinal P-glycoprotein by Spironolactone and Its Effect on Absorption of Orally Administered Digoxin-Reference-Cited by-同舟云学术

Induction of Rat Intestinal P-glycoprotein by Spironolactone and Its Effect on Absorption of Orally Administered Digoxin

Published:2006-06-01 Issue:3 Volume:318 Page:1146-1152
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Ghanem Carolina I.,Gómez Paula C.,Arana María C.,Perassolo María,Carpini Griselda Delli,Luquita Marcelo G.,Veggi Luis M.,Catania Viviana A.,Bengochea Laura A.,Mottino Aldo D.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding

2. Effect of spironolactone on the expression of rat hepatic UDP-glucuronosyltransferase

3. Enhancement of intestinal UDP-glucuronosyltranferase activity in partially hepatectomized rats1This work was presented in part at the meeting of the American Association for the Study of Liver Diseases (AASLD), Chicago, IL, November 8–12, 1996, and published in abstract form (Hepatology 24 (4): 204A, 1996).1

4. The Mucosa of the Small Intestine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of potential drug–drug interactions among outpatients in a tertiary care hospital: focusing on the role of P-glycoprotein and CYP3A4 (retrospective observational study);Heliyon;2022-11

2. Effect of Atorvastatin on Single Oral Pharmacokinetics and Safety of Daclatasvir in Rats: Emphasis on P-glycoprotein and Cytochrome P450;Current Drug Metabolism;2022-05

3. Changes in digoxin pharmacokinetics associated with hepatic P‐glycoprotein upregulation in rats with non‐alcoholic fatty liver disease;Fundamental & Clinical Pharmacology;2021-05-21

4. The Effects of Spironolactone in Preventing Bile Duct Ligation-induced Hepatitis in A Rat Model;IRAN J PHARM RES;2021

5. Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence;Experimental Eye Research;2019-10